Trending Now
LATEST ARTICLES
The First Prescription Digital Therapeutic for Anxiety & Depression
Happify Health launched Ensemble, the first and only transdiagnostic prescription digital therapeutic for the treatment of patients who have Major Depressive Disorder (MDD) or...
The Specialty Pharmacy Power Shift: Why Dispensing Networks Are Becoming Marketing Channels
The traditional role of specialty pharmacies has changed dramatically. Once viewed mainly as dispensing and distribution partners, specialty pharmacies now play a larger role...
From Prescription to Shelf: How Pharma Brands Survive the OTC Transition
The journey from prescription-only treatment to an over-the-counter product is one of the most significant transformations a pharmaceutical brand can experience. While regulatory approval...
Why Clinical Trial Recruitment Has Become Pharma’s Next Commercial Battleground
Drug development has never been more expensive, competitive, or time-sensitive. While scientific innovation continues to advance at a rapid pace, many pharmaceutical companies face...
The New Pharma Gatekeeper Isn’t a Physician, It’s Procurement
For decades, pharmaceutical commercial teams focused primarily on physicians, clinical leaders, and formulary committees. However, healthcare economics are changing rapidly. As health systems face...
Drug Shortages Changed the Rules: When Reliability Becomes a Marketing Advantage
Drug shortages have become one of the defining challenges facing the pharmaceutical industry. In recent years, manufacturing disruptions, raw material shortages, geopolitical instability, and...
The Hidden Referral Battle: How Patient Routing Reshapes Market Share
In specialty healthcare markets, many organizations still focus heavily on awareness campaigns, media spending, and brand visibility. While these efforts remain important, they are...
The Stakeholder Pharma Keeps Missing: Why Employers Matter More Than Ever
For years, pharmaceutical commercial teams have focused heavily on healthcare providers, payers, and patients. Yet another influential stakeholder has steadily gained power in shaping...
The Global Launch Playbook Is Changing: Why Sequencing Matters More Than Speed
For years, pharmaceutical companies pursued a simple objective: launch new therapies in as many markets as possible and as quickly as possible. However, today’s...
Why the Most Important Specialty Pharma Markets Aren’t Always the Biggest Ones
When pharmaceutical marketers evaluate market opportunity, the instinct is often to focus on population size. Larger metropolitan areas usually offer more patients, more providers,...
The AI-Bias Audit: Why Pharma Marketers Must Champion Clinical Fairness
Artificial intelligence is rapidly transforming healthcare. From diagnostic support tools to treatment recommendations and patient engagement platforms, AI is becoming a critical part of...
